Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia
Clinical Audit · 2017
DOI: 10.2147/ca.s122952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Audit, 2017. Verfasst von Ayla Tourkmani und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tourkmani, A., Alharbi, T., Abdelhay, O., khashan, H. A., Obaikan, A. J. A., Alaboud, A., Bakhiet, A., Alqahtani, H., Battal, S. A., & Abanami, N. (2017). Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia. Clinical Audit. https://doi.org/10.2147/ca.s122952
Vancouver
Tourkmani A, Alharbi T, Abdelhay O, khashan HA, Obaikan AJA, Alaboud A, et al. Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia. Clinical Audit. 2017. doi:10.2147/ca.s122952
BibTeX
@article{Tourkmani2017,
author = {Tourkmani, Ayla and Alharbi, Turki and Abdelhay, Osama and khashan, Hesham Al and Obaikan, Al Joharah Al and Alaboud, Aboud and Bakhiet, Ahmed and Alqahtani, Hala and Battal, Saad Al and Abanami, Nawaf},
title = {Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia},
journal = {Clinical Audit},
year = {2017},
doi = {10.2147/ca.s122952}
}
EUVIMED